The institute completed early-stage human trials, known as Phase II, earlier this month.Russia also expects to register a second vaccine by 15 October
Russia has completed clinical trials of a second potential vaccine against Covid-19, developed by Siberia’s Vector Institute, the RIA news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Wednesday.
The institute completed early-stage human trials, known as Phase II, earlier this month.
Earlier this month, this second Covid-19 vaccine, which has been named ‘EpiVacCorona,’ has completed early-stage human trials few weeks back, according to reports.
“14 persons were vaccinated during the first phase, and 43 more during the second phase. Forty-three more volunteers from the placebo control group received a placebo”, Rospotrebnadzor Russia’s consumer rights protection and human well-being watchdog had earlier said, according to Sputnik News.
The watchdog added that all the volunteers taking part in the clinical trials of the Covid-19 vaccine are feeling fine.
He also said the volunteers only experienced sensitivity at the injection site, but other than that did not have any side effects.
Meanwhile, Russia also expects to…
Read full article